Marc Cantillon
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Marc Cantillon
Marc Cantillon was last confirmed as Board Member at Reviva Pharmaceuticals Holdings, Inc. (RVPH) in a filing dated October 26, 2021. The proxy statement of Reviva Pharmaceuticals Holdings, Inc. reports total compensation of $348,587 for Marc Cantillon in fiscal 2022, including a base salary of $233,087. Disclosed compensation is on record for 4 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Start not stated–2021-10-26
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2022 | Reviva Pharmaceuticals Holdings, Inc. (RVPH) | Former Chief Medical Officer | $233,087 | $348,587 |
| 2021 | Reviva Pharmaceuticals Holdings, Inc. (RVPH) | Former Chief Medical Officer | $385,000 | $501,981 |
| 2020 | Reviva Pharmaceuticals Holdings, Inc. (RVPH) | Former Chief Medical Officer | $46,042 | $46,042 |
| 2019 | Reviva Pharmaceuticals Holdings, Inc. (RVPH) | Chief Medical Officer | — | — |
Recent activity
No call appearances or filed executive changes recorded yet.